2 Heavily Shorted Healthcare Stocks to Watch Today

Both stocks have a short-interest ratio above 5

Mar 27, 2018 at 10:11 AM
facebook X logo linkedin

Biotech stock AnaptysBio Inc (NASDAQ:ANAB) is trading higher today after the company reported positive mid-stage trial results for its experimental peanut allergy drug. ANAB shares were last seen up 0.3% at $114.21, but that's nothing new. The security has continued to push higher since its huge bull gap back in October, reaching a record high of $134 back on Feb. 20.

Analysts continue to like the equity, with all six in coverage saying it's a buy. In fact, Stifel this morning upped its price target to $152 from $139, saying it only expects data from the peanut allergy drug trials to improve going forward. Jefferies, which has a $145 price target for ANAB, says the trial update removes an overhang for the shares.

Short interest on AnaptysBio remains elevated, though. In the last two reporting periods the number of shares held by short sellers increased by 7.4%, putting 10.4% of the total float in their hands. Going by average daily volumes, it would take more than seven days to cover these positions.

Elsewhere, women's health expert Hologic, Inc. (NASDAQ:HOLX) is also on the right side of breakeven, trading up 1% at $38.03, thanks to news the Food and Drug Administration (FDA) approved the latest updates to the company's 3Dimensions mammography system. While HOLX shares remain roughly 11% lower year-to-date, they've been consolidating atop their August-October lows, hinting at a layer of technical support.

Analysts are bullish on this security, as well. Specifically, 11 of the 16 in coverage have "strong buy" or "buy" ratings. On the other hand, short interest jumped almost 10% in the last two reporting periods, and accounts for 4% of the total float now. While that may not seem substantial, it'd take these bears more than a week to buy back their bets, based on average daily volumes.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI